OpenVSafe by OpenVAERS
Search V-safe

9CD-99486-44247

2 vaccinations 3 coded responses 10 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
331 / FL
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2020-12-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · None
    Adult check-in
  5. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-01-21
    Survey response — day 14, dose 2
    MedDRA: Squamous cell carcinoma of lung, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Diagnosed last week with squamous cell lung cancer. · Healthcare visit (other): Staging studies. Meet Med. Oncolgy. & Rad. Oncol. Tomorrow.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-21
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-01-28
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-02-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Survey response — day 35, dose 2
    MedDRA: Dyspnoea, Hospitalisation, Pre-existing disease — Feeling: Fair · Be unable to work
    Free text: Increased.shortness of breath. Admitted to hospital. New left lower lobe infiltrate (where my lung cancer is. Sputum with light growth of MRSA. On iv vancomycin. Also 80 mg prednisone for possible idiosyncratic effect of Keytruda,
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-29
  14. 2021-04-08
    Survey response — 3 months, dose 2
    MedDRA: Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Severe tiredness, slept virtuallly all day but had f I'mll chemotherapy yesterday.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-07-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-17Pfizer-BioNTech
22021-01-07Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — day 14, dose 2

2021-01-21

Symptoms: Diagnosed last week with squamous cell lung cancer.
Healthcare visit (other): Staging studies. Meet Med. Oncolgy. & Rad. Oncol. Tomorrow.

Release 4 — day 35, dose 2

2021-02-11

Symptoms: Increased.shortness of breath. Admitted to hospital. New left lower lobe infiltrate (where my lung cancer is. Sputum with light growth of MRSA. On iv vancomycin. Also 80 mg prednisone for possible idiosyncratic effect of Keytruda,

Release 7 — 3 months, dose 2

2021-04-08

Symptoms: Severe tiredness, slept virtuallly all day but had f I'mll chemotherapy yesterday.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHospitalisation ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDSquamous cell carcinoma of lung ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release